Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease.

Autor: Mielke MM; Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Anderson M; Atrium Health, Charlotte, North Carolina, USA., Ashford JW; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.; War Related Illness and Injury Study Center, VA Palo Alto Health Care System, Palo Alto, California, USA., Jeromin A; ALZpath, Carlsbad, California, USA., Lin PJ; Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA., Rosen A; Palo Alto Veterans Affairs Medical Center, Palo Alto, California, USA.; Stanford University School of Medicine, Stanford, California, USA., Tyrone J; Patient Advocate, California, USA., VandeVrede L; Memory and Aging Center, Department of Neurology, University of California, San Francisco, California, USA., Willis D; Department of Family Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA., Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden., Khachaturian AS; The Campaign to Prevent Alzheimer's Disease, Rockville, Maryland, USA., Schindler SE; Department of Neurology, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, USA., Weiss J; US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Workforce, Rockville, Maryland, USA., Batrla R; Eisai Inc., Nutley, New Jersey, USA., Bozeat S; F. Hoffman-La Roche AG, Basel, Switzerland., Dwyer JR; Global Alzheimer's Platform Foundation, Washington, District of Columbia, USA., Holzapfel D; The Global CEO Initiative on Alzheimer's Disease, Philadelphia, Pennsylvania, USA.; Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA., Jones DR; Eisai Inc., Nutley, New Jersey, USA., Murray JF; Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA., Partrick KA; The Global CEO Initiative on Alzheimer's Disease, Philadelphia, Pennsylvania, USA., Scholler E; The Global CEO Initiative on Alzheimer's Disease, Philadelphia, Pennsylvania, USA.; Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA., Vradenburg G; The Global CEO Initiative on Alzheimer's Disease, Philadelphia, Pennsylvania, USA.; Davos Alzheimer's Collaborative, Philadelphia, Pennsylvania, USA., Young D; Guidehouse, McLean, Virginia, USA., Braunstein JB; C2N Diagnostics, St. Louis, Missouri, USA., Burnham SC; Eli Lilly & Co., Indianapolis, Indiana, USA., de Oliveira FF; Federal University of São Paulo, São Paulo, Brazil., Hu YH; Eisai Inc., Nutley, New Jersey, USA., Mattke S; The USC Brain Health Observatory, University of Southern California, Los Angeles, California, USA., Merali Z; Brain and Mind Institute, Aga Khan University, Nairobi, Kenya., Monane M; C2N Diagnostics, St. Louis, Missouri, USA., Sabbagh MN; Barrow Neurological Institute, Phoenix, Arizona, USA., Shobin E; Biogen, Cambridge, Massachusetts, USA., Weiner MW; Departments of Radiology and Biomedical Imaging, Medicine, Psychiatry, and Neurology, University of California, San Francisco, California, USA., Udeh-Momoh CT; Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.; Brain and Mind Institute, Aga Khan University, Nairobi, Kenya.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Nov; Vol. 20 (11), pp. 8209-8215. Date of Electronic Publication: 2024 Oct 06.

Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease.

Autor: Schindler SE; Department of Neurology, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St Louis, MO, USA. schindler.s.e@wustl.edu., Galasko D; Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA., Pereira AC; Department of Neurology, Icahn School of Medicine, Mount Sinai, New York, NY, USA., Rabinovici GD; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.; Department of Radiology and Biomedical Imaging, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA., Salloway S; Department of Neurology, Alpert Medical School, Brown University, Providence, RI, USA., Suárez-Calvet M; Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain., Khachaturian AS; The Campaign to Prevent Alzheimer's Disease, Rockville, MD, USA., Mielke MM; Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Udeh-Momoh C; Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Weiss J; US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Health Workforce, Rockville, MD, USA., Batrla R; Eisai Inc., Nutley, NJ, USA., Bozeat S; F. Hoffman-La Roche AG, Basel, Switzerland., Dwyer JR; Global Alzheimer's Platform Foundation, Washington, DC, USA., Holzapfel D; The Global CEO Initiative on Alzheimer's Disease, Philadelphia, PA, USA., Jones DR; Eisai Inc., Nutley, NJ, USA., Murray JF; Davos Alzheimer's Collaborative, Philadelphia, PA, USA., Partrick KA; The Global CEO Initiative on Alzheimer's Disease, Philadelphia, PA, USA., Scholler E; The Global CEO Initiative on Alzheimer's Disease, Philadelphia, PA, USA., Vradenburg G; Davos Alzheimer's Collaborative, Philadelphia, PA, USA.; UsAgainstAlzheimer's, Washington, DC, USA., Young D; Guidehouse, McLean, VA, USA., Algeciras-Schimnich A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Aubrecht J; Prothena Biosciences Inc., Brisbane, CA, USA., Braunstein JB; C2N Diagnostics, St Louis, MO, USA., Hendrix J; Eli Lilly and Company, Indianapolis, IN, USA., Hu YH; Eisai Inc., Nutley, NJ, USA., Mattke S; The USC Brain Health Observatory, University of Southern California, Los Angeles, CA, USA., Monane M; C2N Diagnostics, St Louis, MO, USA., Reilly D; Guidehouse, McLean, VA, USA., Somers E; Eisai Inc., Nutley, NJ, USA., Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universitiet, Amsterdam, The Netherlands., Shobin E; Biogen, Cambridge, MA, USA., Vanderstichele H; Biomarkable BV, Gent, Belgium., Weiner MW; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.; Department of Medicine, University of California, San Francisco, CA, USA.; Department of Psychiatry, University of California, San Francisco, CA, USA.; Department of Neurology, University of California, San Francisco, CA, USA., Wilson D; Quanterix Corporation, Billerica, MA, USA., Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. oskar.hansson@med.lu.se.; Memory Clinic, Skåne University Hospital, Malmö, Sweden. oskar.hansson@med.lu.se.

Publikováno v: Nature reviews. Neurology [Nat Rev Neurol] 2024 Jul; Vol. 20 (7), pp. 426-439. Date of Electronic Publication: 2024 Jun 12.

Ingestion of probiotic (Lactobacillus helveticus and Bifidobacterium longum) alters intestinal microbial structure and behavioral expression following social defeat stress.

Autor: Partrick KA; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA., Rosenhauer AM; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA., Auger J; Rosell Institute for Microbiome and Probiotics, Montreal, QC, Canada., Arnold AR; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA., Ronczkowski NM; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA., Jackson LM; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA., Lord MN; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA., Abdulla SM; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA., Chassaing B; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA.; INSERM U1016, Team 'Mucosal Microbiota in Chronic Inflammatory Diseases', CNRS UMR 8104, Université de Paris, Paris, France.; Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA., Huhman KL; Neuroscience Institute, Center for Behavioral Neuroscience, Georgia State University, PO Box 5030, Atlanta, GA, 30303-5030, USA. khuhman@gsu.edu.

Publikováno v: Scientific reports [Sci Rep] 2021 Feb 12; Vol. 11 (1), pp. 3763. Date of Electronic Publication: 2021 Feb 12.

Corrigendum to "Acute and repeated exposure to social stress reduces gut microbiota diversity in Syrian hamsters" [Behav. Brain Res. 345 (2018) 39-48].

Autor: Partrick KA; Neuroscience Institute, Georgia State University, GA, 30303, USA. Electronic address: kpartrick1@student.gsu.edu., Chassaing B; Neuroscience Institute, Georgia State University, GA, 30303, USA; Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, GA, 30303, USA., Beach LQ; Neuroscience Institute, Georgia State University, GA, 30303, USA., McCann KE; Neuroscience Institute, Georgia State University, GA, 30303, USA., Gewirtz AT; Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, GA, 30303, USA., Huhman KL; Neuroscience Institute, Georgia State University, GA, 30303, USA.

Publikováno v: Behavioural brain research [Behav Brain Res] 2018 Aug 01; Vol. 348, pp. 277. Date of Electronic Publication: 2018 Apr 16.

Inter-individual variation in weaning among rhesus macaques (Macaca mulatta): Serum stable isotope indicators of suckling duration and lactation.

Autor: Reitsema LJ; Departmentof Anthropology, University of Georgia, Athens, Georgia. reitsema@uga.edu., Partrick KA; Neuroscience Institute, Georgia State University, Atlanta, Georgia., Muir AB; Department of Pediatrics, Emory University, Atlanta, Georgia.

Publikováno v: American journal of primatology [Am J Primatol] 2016 Oct; Vol. 78 (10), pp. 1113-34. Date of Electronic Publication: 2015 Aug 18.